omniture
CSTONE PHARMACEUTICALS

Latest News

CStone Pharmaceuticals listed on the Hong Kong Stock Exchange today

HONG KONG, Feb. 26, 2019 /PRNewswire/ -- CStone Pharmaceuticals (Stock code: 2616) today announce...

2019-02-27 10:47 6312

Avapritinib receives Phase III clinical trial approval for GIST in China

SUZHOU, China, Feb. 15, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone") today announced that...

2019-02-15 23:19 1866

CStone and IMPACT Therapeutics' clinical collaboration progresses to IND filing acceptance for CS1001+IMP4297 combination therapy

SUZHOU, China, Feb. 2, 2019 /PRNewswire/ -- CStone Pharmaceutical ("CStone") and IMPACT Therapeutic...

2019-02-08 03:10 577

CStone receives CTA approval in China to start Phase I trial for FGFR4 inhibitor BLU-554 (CS3008)

SUZHOU, China, Jan. 28, 2019 /PRNewswire/ -- CStone Pharmaceuticals (CStone) today announced that t...

2019-01-29 10:19 363

CStone Pharmaceuticals announces initiation of CS1001 Phase I Study in U.S., patient enrollment under way

SUZHOU, China, Dec. 21, 2018 /PRNewswire/ -- CStone Pharmaceuticals ("CStone") today announced the ...

2018-12-21 17:50 560

CStone initiates a bridging Phase I clinical trial for PD-1 antibody CS1003 with first patient dosed in China

SUZHOU, China, Nov. 19, 2018 /PRNewswire/ -- CStone Pharmaceuticals (CStone) today announced that a...

2018-11-19 12:54 569

CStone announces first patient dosed in Phase I study in China for MEK inhibitor CS3006

SUZHOU, China, Oct. 29, 2018 /PRNewswire/ -- CStone Pharmaceuticals (CStone) today announced the in...

2018-10-30 10:28 500

CStone Receives US FDA IND Approval for Recombinant PD-1 mAb CS1003

SUZHOU, China, Oct. 23, 2018 /PRNewswire/ -- CStone Pharmaceuticals ("CStone") today announced that...

2018-10-24 10:08 493

CStone Receives U.S. IND Approval for PD-L1 Antibody CS1001

SUZHOU, China, Oct. 16, 2018 /PRNewswire/ -- CStone Pharmaceuticals ("CStone") today announced the ...

2018-10-16 16:48 494

CStone's Anti-CTLA-4 Antibody CS1002 Receives IND Approval in China

SUZHOU, China, Aug. 27, 2018 /PRNewswire/ -- CStone Pharmaceuticals (CStone) announced today that i...

2018-08-28 10:16 509

CStone's MEK Inhibitor CS3006 Receives IND Approval in China

SUZHOU, China, July 30, 2018 /PRNewswire/ -- CStone Pharmaceuticals (CStone) today announced that i...

2018-07-30 12:51 551

CStone's PD-1 inhibitor CS1003 receives clinical trial approval in China

SUZHOU, China, July 12, 2018 /PRNewswire/ -- CStone Pharmaceuticals (SuZhou) Co . LTD (CStone), a pr...

2018-07-12 12:45 679

CStone enrolls first patient in Phase I study for MEK inhibitor CS3006 in Australia

SUZHOU, China, June 20, 2018 /PRNewswire/ -- CStone Pharmaceuticals (CStone) today announced the in...

2018-06-20 19:07 895

CStone Pharmaceuticals Initiates Two Pivotal Phase II Studies of the Anti-PD-L1 Monoclonal Antibody CS1001

SUZHOU, China, June 13, 2018 /PRNewswire/ -- CStone Pharmaceuticals ("CStone") today announced that...

2018-06-13 15:09 985

CStone announces first patient dosing with anti-PD-1 antibody CS1003 in Phase I study in Australia

SUZHOU, China, May 14, 2018 /PRNewswire/ -- CStone Pharmaceuticals (CStone) today announced dosing ...

2018-05-14 18:36 722

CStone Raises $260 million in Series B Financing to Advance Novel Cancer Therapies

SUZHOU, China, May 8, 2018 /PRNewswire/ -- CStone Pharmaceuticals ("CStone") announced today the su...

2018-05-09 11:18 737

CStone announces first patient dosed with anti-CTLA-4 antibody CS1002 of a Phase I study in Australia

SUZHOU, China, May 4, 2018 /PRNewswire/ -- CStone Pharmaceuticals (Suzhou) Co., Ltd., (CStone) toda...

2018-05-04 14:47 1326

CStone's anti-CTLA-4 antibody CS1002 filed for clinical trial approval in Australia

SUZHOU, China, Dec. 29, 2017 /PRNewswire/ -- CStone Pharmaceuticals (Suzhou) Co., Ltd, today announ...

2017-12-29 21:00 682

CStone files CS1003, an anti-PD-1 antibody, for clinical trial approval in Australia

SUZHOU, China, Dec. 27, 2017 /PRNewswire/ -- CStone Pharmaceuticals (Suzhou) Co., Ltd., (CStone) to...

2017-12-28 10:45 680
12345